These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 8457657

  • 21. Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines.
    Shainoff JR, Stearns DJ, DiBello PM, Hishikawa-Itoh Y.
    Thromb Haemost; 1990 Apr 12; 63(2):193-203. PubMed ID: 2163552
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW, Siebenlist KR, DiOrio JP, Matsuda M, Hainfeld JF, Wall JS.
    J Clin Invest; 1995 Aug 12; 96(2):1053-8. PubMed ID: 7635941
    [Abstract] [Full Text] [Related]

  • 26. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE.
    Thromb Haemost; 1999 Aug 12; 82(2):673-83. PubMed ID: 10605767
    [Abstract] [Full Text] [Related]

  • 27. Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.
    Plow EF, Edgington TS.
    J Clin Invest; 1975 Dec 12; 56(6):1509-18. PubMed ID: 53241
    [Abstract] [Full Text] [Related]

  • 28. The polymerization of fibrinogen Dusart (A alpha 554 Arg-->Cys) after removal of carboxy terminal regions of the A alpha-chains.
    Siebenlist KR, Mosesson MW, DiOrio JP, Soria J, Soria C, Caen JP.
    Blood Coagul Fibrinolysis; 1993 Feb 12; 4(1):61-5. PubMed ID: 8457653
    [Abstract] [Full Text] [Related]

  • 29. A neoantigenic determinant in coiled coil region of human fibrin beta-chain.
    Lugovskoy EV, Gritsenko PG, Kolesnikova IN, Lugovskaya NE, Komisarenko SV.
    Thromb Res; 2009 Mar 12; 123(5):765-70. PubMed ID: 18977516
    [Abstract] [Full Text] [Related]

  • 30. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
    Thiel W, Delvos U, Müller-Berghaus G.
    Thromb Haemost; 1985 Aug 30; 54(2):533-8. PubMed ID: 4082091
    [Abstract] [Full Text] [Related]

  • 31. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
    Lugovskoy EV, Gritsenko PG, Kolesnikova IN, Zolotarova EN, Chernishov VI, Nieuwenhuizen W, Komisarenko SV.
    Thromb Res; 2004 Aug 30; 113(3-4):251-9. PubMed ID: 15140590
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products.
    Chen F, Haber E, Matsueda GR.
    Thromb Haemost; 1992 Mar 02; 67(3):335-40. PubMed ID: 1379385
    [Abstract] [Full Text] [Related]

  • 34. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
    Rinsho Byori; 2001 Mar 02; 49(3):283-9. PubMed ID: 11307330
    [Abstract] [Full Text] [Related]

  • 35. [Properties of 2 fibrin monomer forms which differ in the degree of thrombin activation. Relation of these 2 forms to specific polymerization inhibitors].
    Lugovskoi EV, Tsariuk LA, Gogolinskaia GK, Derzskaia SG, Belitser VA.
    Biokhimiia; 1978 Jul 02; 43(7):1162-6. PubMed ID: 698303
    [Abstract] [Full Text] [Related]

  • 36. [The role of complementary E2 and D2 centers in the reaction between fibrin and fibrinogen].
    Ugarova TP, Kalikhevich VN, Ardemasova ZA, Belitser VA.
    Biokhimiia; 1987 Feb 02; 52(2):255-63. PubMed ID: 3567249
    [Abstract] [Full Text] [Related]

  • 37. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S.
    Rinsho Byori; 2004 Apr 02; 52(4):355-61. PubMed ID: 15164605
    [Abstract] [Full Text] [Related]

  • 38. The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
    Lu PD, Galanakis DK, Ghebrehiwet B, Peerschke EI.
    Clin Immunol; 1999 Mar 02; 90(3):360-7. PubMed ID: 10075865
    [Abstract] [Full Text] [Related]

  • 39. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA, Lugovskoĭ EV, Ugarova TP, Derzskaia SG.
    Biokhimiia; 1985 Aug 02; 50(8):1336-41. PubMed ID: 4074798
    [Abstract] [Full Text] [Related]

  • 40. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
    Lounes KC, Lefkowitz JB, Coates AI, Hantgan RR, Henschen-Edman A, Lord ST.
    Ann N Y Acad Sci; 2001 Aug 02; 936():129-32. PubMed ID: 11460470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.